| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 12/27/2001 | US20010055570 Cyclic guanosine 3',5'-monophosphate phosphodiesterases (cGMP PDEs); using specified pyrazolopyrimidinone or aminoquinazoline derivatives |
| 12/27/2001 | US20010055569 Nasal drug delivery composition |
| 12/27/2001 | CA2414228A1 Secreted epithelial colon stromal-1 polypeptides, nucleic acids encoding the same and uses thereof |
| 12/27/2001 | CA2414085A1 Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 12/27/2001 | CA2414046A1 Conserved diaphanous-related formin autoregulatory domain (dad) |
| 12/27/2001 | CA2414020A1 Methods and compositions for the treatment of peripheral artery disease |
| 12/27/2001 | CA2414015A1 Human receptors |
| 12/27/2001 | CA2414010A1 Secreted redox proteins |
| 12/27/2001 | CA2413878A1 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
| 12/27/2001 | CA2413866A1 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations |
| 12/27/2001 | CA2413554A1 Biotransformation of biologically active compounds made of various classes of chemical substances by means of laccase and manganese peroxidase enzymes |
| 12/27/2001 | CA2413452A1 Clk-2, cex-7 and coq-4 genes, and uses thereof |
| 12/27/2001 | CA2413435A1 A recombinant cell line expressing gpcrx11 as a functional receptor validated by angiopeptin and useful for screening of agonists and antagonists |
| 12/27/2001 | CA2413421A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/27/2001 | CA2413418A1 Piperidine amides as modulators of chemokine receptor activity |
| 12/27/2001 | CA2413328A1 Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy |
| 12/27/2001 | CA2413277A1 Use of microsomal triglyceride transfer protein (mtp) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (pptrl) |
| 12/27/2001 | CA2412985A1 Hiv integrase inhibitors |
| 12/27/2001 | CA2412141A1 Indole derivatives useful for the treatment of cns disorders |
| 12/27/2001 | CA2411978A1 Transgenic mice containing targeted gene disruptions |
| 12/27/2001 | CA2411865A1 Azaindole derivatives, process for their preparation, and their use as antitumor agents |
| 12/27/2001 | CA2411756A1 Mutation associated with epilepsy |
| 12/27/2001 | CA2411585A1 Novel non-psychotropic cannabinoids |
| 12/27/2001 | CA2411553A1 New use of angiotensin ii antagonists |
| 12/27/2001 | CA2411255A1 Novel compounds |
| 12/27/2001 | CA2411236A1 Combinations and compositions which interfere with vegf/vegf and angiopoietin/tie receptor function and their use (ii) |
| 12/27/2001 | CA2411102A1 Cold anti-cd20 antibody/radiolabeled anti-cd22 antibody combination |
| 12/27/2001 | CA2411100A1 New formulation comprising a betablocker and optionally a cholesterol-lowering agent |
| 12/27/2001 | CA2410864A1 Compositions comprising net-4 modulations and their use for treating neoplastic disease |
| 12/27/2001 | CA2410632A1 Nitrosated and nitrosylated taxanes, compositions and methods of use |
| 12/27/2001 | CA2410447A1 Bis-arylsulfones |
| 12/27/2001 | CA2410371A1 Methods for enhancing antibody-induced cell lysis and treating cancer |
| 12/27/2001 | CA2409781A1 Phosphodiesterases |
| 12/27/2001 | CA2409776A1 G-protein coupled receptors |
| 12/26/2001 | CN1328569A TGF (b) 1 inhibitor peptides |
| 12/26/2001 | CN1328555A Novel salts of pyridopyrazine compound and crystals thereof |
| 12/26/2001 | CN1328554A Eletriptan hydrobromide monohydrate |
| 12/26/2001 | CN1328552A Pyrimidone derivatives |
| 12/26/2001 | CN1328550A Oxazole compounds as prostaglandin E2 agonists or antagonists |
| 12/26/2001 | CN1328549A Substituted benzo [de] isoquinoline-1,3-diones |
| 12/26/2001 | CN1328548A Benzamide derivatives as thrombin inhibitors |
| 12/26/2001 | CN1328547A 2,3-Disubstituted pyridine derivatives, process for preparation thereof, drug compositions containing the same and intermediates for preparation |
| 12/26/2001 | CN1328546A Pyrrolidines as inhibitors of neuraminidases |
| 12/26/2001 | CN1328538A 2,4-pentadienoic acid derivatives having selective activity for retinoid X(RXR) receptors |
| 12/26/2001 | CN1328473A Medicinal aerosol formulation |
| 12/26/2001 | CN1328469A Use of parvovirus capsid particles in inhibition of cell proliferation and migration |
| 12/26/2001 | CN1328456A Use of thiazolidinediones derivatives for preventing uterine contractions in premature labour or lactation |
| 12/26/2001 | CN1328454A Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
| 12/26/2001 | CN1327844A Chinese medicine for relieving fatigue and resisting oxygen lack and its preparing process |
| 12/26/2001 | CN1327820A Lotion for treating anal diseases |
| 12/26/2001 | CN1327793A Pyrrolo-triazine and pyrimidine compounds |
| 12/26/2001 | CN1327768A Health-care aloe beverage |
| 12/26/2001 | CN1076624C Nasally administrable compositions |
| 12/26/2001 | CN1076621C Capsule for treatment of rheumatic angitis and its preparation method |
| 12/26/2001 | CN1076620C Health-care oral liquor |
| 12/26/2001 | CN1076619C Moxiburning medicine for acupoint therapy |
| 12/26/2001 | CN1076618C Liquid medicine for treating wound and pain and preparing process thereof |
| 12/25/2001 | US6333410 Process for the preparation and purification of thiol-containing maytansinoids |
| 12/25/2001 | US6333402 For therapy and diagnosis |
| 12/25/2001 | US6333354 Synergistic combination of PDE inhibitors and adenylate cyclase agonists or guanyl cyclyse agonists |
| 12/25/2001 | US6333353 Nutrients, foods, drugs |
| 12/25/2001 | US6333344 Prolines as antimicrobial agents |
| 12/25/2001 | US6333339 3-Benzylpiperidine |
| 12/25/2001 | US6333338 Anticoagulants, cardiovascular disorders |
| 12/25/2001 | US6333336 Pyrazolo-pyridine derivatives as ligands for GABA receptors |
| 12/25/2001 | US6333334 Use of macrolide compounds for the treatment of ARDS |
| 12/25/2001 | US6333331 Useful in inactivating the human dna repair protein o.sup.6 -alkylguanine-dna alkyltransferase; anticancer agents |
| 12/25/2001 | US6333328 Serotonin 5-HT3 receptor partial activator |
| 12/25/2001 | US6333324 For therapy and prophylaxis of matrix metalloproteinases (mmp) or tumor necrosis factor .alpha. (tnf.alpha.), mediated diseases |
| 12/25/2001 | US6333318 Used in therapy; for delivering recombinant proteins into a variety of cells within a patient |
| 12/25/2001 | US6333311 Has inflammatory and immune response functions such as regulation of monocyte colony stimulating factor synthesis, regulation of interleukin synthesis, activation of natural killer cell activity, inhibition of metastasis |
| 12/25/2001 | US6333168 Cloning, expression and uses of dorsalin-1 |
| 12/25/2001 | US6333035 Administering monoclonal antibody against a human t-cell leukemia virus-derived transcription activating factor p40tax-induced cell membrane glycoprotein of 34 kda (gp34) in an amount effective for treating rheumatoid arthritis |
| 12/25/2001 | CA2209313C Heterocycle-fused thiazole derivatives |
| 12/25/2001 | CA2172779C Cgrp antagonist used for the treatment of pruritus and ocular or palpebral dysesthesia |
| 12/25/2001 | CA2094027C Osteogenic peptides |
| 12/25/2001 | CA2081348C Veterinary formulation of amoxycillin and clavulanic acid, and derivatives thereof |
| 12/25/2001 | CA2068590C Process and intermediates for the preparation of spiro¬isoquinoline-4(1h),3'-pyrrolidine|-1,2',3,5'(2h)-tetrones which are useful as aldose reductase inhibitors |
| 12/25/2001 | CA2066728C Anti-tumor preparation comprising interleukin-2 and histamine, analogs thereof or h2-receptor agonists |
| 12/21/2001 | CA2351125A1 Substituted nitrated catechols, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them |
| 12/20/2001 | WO2001096586A1 Antisense modulation of c/ebp alpha expression |
| 12/20/2001 | WO2001096558A1 Polyfunctional base sequence and artificial gene containing the same |
| 12/20/2001 | WO2001096557A2 A human homologue of the dbf4/ask1 protein, nucleic acids, and methods related to the same |
| 12/20/2001 | WO2001096547A2 Human kinases |
| 12/20/2001 | WO2001096546A2 Protein phosphatases |
| 12/20/2001 | WO2001096393A2 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
| 12/20/2001 | WO2001096388A2 Compositions and methods for the therapy and diagnosis of colon cancer |
| 12/20/2001 | WO2001096376A2 Pro-apoptotic fragments of the dengue virus envelope glycoproteins |
| 12/20/2001 | WO2001096356A1 Antisense molecules and method of controlling expression of gene function by using the same |
| 12/20/2001 | WO2001096354A1 Combinatorial production of nucleotide and nucleoside (xitp)analogues |
| 12/20/2001 | WO2001096353A2 3'-PRODRUGS OF 2'-DEOXY-β-L-NUCLEOSIDES |
| 12/20/2001 | WO2001096347A1 HMG-CoA REDUCTASE INHIBITORS AND METHOD |
| 12/20/2001 | WO2001096345A1 Tetrapyrroles |
| 12/20/2001 | WO2001096338A1 Non-nucleoside reverse transcriptase inhibitors |
| 12/20/2001 | WO2001096337A1 4-oxoimidazolidine-2-spiro-nitrogenous heterocycle compounds |
| 12/20/2001 | WO2001096336A2 6,5-fused bicyclic heterocycles |
| 12/20/2001 | WO2001096334A2 Heteroarylalkanoic acids as integrin receptor antagonists |
| 12/20/2001 | WO2001096331A1 Lactam inhibitors of factor xa and method |
| 12/20/2001 | WO2001096330A2 Thrombin receptor antagonists |
| 12/20/2001 | WO2001096327A1 BIOISOSTERIC BENZAMIDE DERIVATIVES AND THEIR USE AS APoB-100 SECRETION INHIBITORS |